PURPOSE: To overcome the problem of antibody availability, often encountered during chromatin immunoprecipitation (ChIP) assays, nickel agarose-based chromatin enrichment (NACE) was developed. Based on the affinity of (His)-6-tagged proteins for the nickel ion, this modified form of ChIP allows the isolation of chromatin in the absence of specific antibodies. METHODS: Nonpigmented ciliary epithelium cells were transfected with (His)-6-tagged FOXC1. FOXC1-enriched chromatin complexes were isolated by using the tight electrostatic interaction between histidine residues of the recombinant FOXC1 protein and nickel. One hundred fifty NACE-enriched clones were sequenced and subjected to in silico and biochemical analyses. RESULTS: Twenty-six clones were detected near known genes: Eight were near predicted but uncharacterized genes, eight were within areas where neither known nor predicted genes have yet been mapped, four were chimeric, and the rest were either repetitive (n=81) or poor-quality (n=23) sequences. Twenty of the 26 known genes were expressed in the eye. Five of the NACE-enriched clones (BMP2K, DACH, FVT-1, SIX-1, and PGE-2 receptor), as well as nine clones selected from the literature, were validated by PCR amplification in two independent lots of NACE-enriched chromatin. All five NACE-selected genes were detected in two independent assays, as well as four (BMP7, SMAD2, TGF-B1, and WNT6) of the nine genes selected from the literature, consistent with these genes' being regulated by FOXC1. CONCLUSIONS: NACE is a useful technique allowing specific chromatin enrichment in cases where antibodies are unavailable. Specific recovery of PTGER, DACH1, WNT6, and FVT-1 implicates FOXC1 in a variety of cellular events including modulation of intraocular pressure, cell cycle, ocular development, and oncogenesis.
PURPOSE: To overcome the problem of antibody availability, often encountered during chromatin immunoprecipitation (ChIP) assays, nickelagarose-based chromatin enrichment (NACE) was developed. Based on the affinity of (His)-6-tagged proteins for the nickel ion, this modified form of ChIP allows the isolation of chromatin in the absence of specific antibodies. METHODS: Nonpigmented ciliary epithelium cells were transfected with (His)-6-tagged FOXC1. FOXC1-enriched chromatin complexes were isolated by using the tight electrostatic interaction between histidine residues of the recombinant FOXC1 protein and nickel. One hundred fifty NACE-enriched clones were sequenced and subjected to in silico and biochemical analyses. RESULTS: Twenty-six clones were detected near known genes: Eight were near predicted but uncharacterized genes, eight were within areas where neither known nor predicted genes have yet been mapped, four were chimeric, and the rest were either repetitive (n=81) or poor-quality (n=23) sequences. Twenty of the 26 known genes were expressed in the eye. Five of the NACE-enriched clones (BMP2K, DACH, FVT-1, SIX-1, and PGE-2 receptor), as well as nine clones selected from the literature, were validated by PCR amplification in two independent lots of NACE-enriched chromatin. All five NACE-selected genes were detected in two independent assays, as well as four (BMP7, SMAD2, TGF-B1, and WNT6) of the nine genes selected from the literature, consistent with these genes' being regulated by FOXC1. CONCLUSIONS:NACE is a useful technique allowing specific chromatin enrichment in cases where antibodies are unavailable. Specific recovery of PTGER, DACH1, WNT6, and FVT-1 implicates FOXC1 in a variety of cellular events including modulation of intraocular pressure, cell cycle, ocular development, and oncogenesis.
Authors: Mao Mao; Richard S Smith; Marcel V Alavi; Jeffrey K Marchant; Mihai Cosma; Richard T Libby; Simon W M John; Douglas B Gould Journal: Invest Ophthalmol Vis Sci Date: 2015-10 Impact factor: 4.799
Authors: Simone Buraschi; Thomas Neill; Rick T Owens; Leonardo A Iniguez; George Purkins; Rajanikanth Vadigepalli; Barry Evans; Liliana Schaefer; Stephen C Peiper; Zi-Xuan Wang; Renato V Iozzo Journal: PLoS One Date: 2012-09-19 Impact factor: 3.240
Authors: Lars M Ittner; Heiko Wurdak; Kerstin Schwerdtfeger; Thomas Kunz; Fabian Ille; Per Leveen; Tord A Hjalt; Ueli Suter; Stefan Karlsson; Farhad Hafezi; Walter Born; Lukas Sommer Journal: J Biol Date: 2005-12-14
Authors: Guillaume de la Houssaye; Ivan Bieche; Olivier Roche; Véronique Vieira; Ingrid Laurendeau; Laurence Arbogast; Hatem Zeghidi; Philippe Rapp; Philippe Halimi; Michel Vidaud; Jean-Louis Dufier; Maurice Menasche; Marc Abitbol Journal: BMC Med Genet Date: 2006-11-29 Impact factor: 2.103
Authors: Caroline Baynes; Catherine S Healey; Karen A Pooley; Serena Scollen; Robert N Luben; Deborah J Thompson; Paul D P Pharoah; Douglas F Easton; Bruce A J Ponder; Alison M Dunning Journal: Breast Cancer Res Date: 2007 Impact factor: 6.466